» Articles » PMID: 15505217

Induction in Myeloid Leukemic Cells of Genes That Are Expressed in Different Normal Tissues

Overview
Specialty Science
Date 2004 Oct 27
PMID 15505217
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Using DNA microarray and cluster analysis of expressed genes in a cloned line (M1-t-p53) of myeloid leukemic cells, we have analyzed the expression of genes that are preferentially expressed in different normal tissues. Clustering of 547 highly expressed genes in these leukemic cells showed 38 genes preferentially expressed in normal hematopoietic tissues and 122 other genes preferentially expressed in different normal nonhematopoietic tissues, including neuronal tissues, muscle, liver, and testis. We have also analyzed the genes whose expression in the leukemic cells changed after activation of WT p53 and treatment with the cytokine IL-6 or the calcium mobilizer thapsigargin. Of 620 such genes in the leukemic cells that were differentially expressed in normal tissues, clustering showed 80 genes that were preferentially expressed in hematopoietic tissues and 132 genes in different normal nonhematopoietic tissues that also included neuronal tissues, muscle, liver, and testis. Activation of p53 and treatment with IL-6 or thapsigargin induced different changes in the genes preferentially expressed in these normal tissues. These myeloid leukemic cells thus express genes that are expressed in normal nonhematopoietic tissues, and various treatments can reprogram these cells to induce other such nonhematopoietic genes. The results indicate that these leukemic cells share with normal hematopoietic stem cells the plasticity of differentiation to different cell types. It is suggested that this reprogramming to induce in malignant cells genes that are expressed in different normal tissues may be of clinical value in therapy.

Citing Articles

Heterogeneity of transcription factor binding specificity models within and across cell lines.

Sharmin M, Corrada Bravo H, Hannenhalli S Genome Res. 2016; 26(8):1110-23.

PMID: 27311443 PMC: 4971765. DOI: 10.1101/gr.199166.115.


The GAS41-PP2Cbeta complex dephosphorylates p53 at serine 366 and regulates its stability.

Park J, Smith R, Shieh S, Roeder R J Biol Chem. 2011; 286(13):10911-7.

PMID: 21317290 PMC: 3064146. DOI: 10.1074/jbc.C110.210211.


Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles.

Bock Axelsen J, Bock-Axelsen J, Lotem J, Sachs L, Domany E Proc Natl Acad Sci U S A. 2007; 104(32):13122-7.

PMID: 17664417 PMC: 1941809. DOI: 10.1073/pnas.0705824104.


Human cancers overexpress genes that are specific to a variety of normal human tissues.

Lotem J, Netanely D, Domany E, Sachs L Proc Natl Acad Sci U S A. 2005; 102(51):18556-61.

PMID: 16339305 PMC: 1317977. DOI: 10.1073/pnas.0509360102.

References
1.
Lotem J, Gal H, Kama R, Amariglio N, Rechavi G, Domany E . Inhibition of p53-induced apoptosis without affecting expression of p53-regulated genes. Proc Natl Acad Sci U S A. 2003; 100(11):6718-23. PMC: 164513. DOI: 10.1073/pnas.1031695100. View

2.
Lotem J, Sachs L . Cytokines as suppressors of apoptosis. Apoptosis. 2003; 4(3):187-96. DOI: 10.1023/a:1009614723237. View

3.
Goolsby J, Marty M, Heletz D, Chiappelli J, Tashko G, Yarnell D . Hematopoietic progenitors express neural genes. Proc Natl Acad Sci U S A. 2003; 100(25):14926-31. PMC: 299854. DOI: 10.1073/pnas.2434383100. View

4.
Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M . Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood. 2003; 103(7):2753-60. DOI: 10.1182/blood-2003-07-2482. View

5.
Hubbell E, Liu W, Mei R . Robust estimators for expression analysis. Bioinformatics. 2002; 18(12):1585-92. DOI: 10.1093/bioinformatics/18.12.1585. View